Pediatric Precision Oncology Study Matches 28 Percent of Patients to Targeted Therapies

Jul

Exploring Tumor Tissue Architecture and Immune Response with Digital Spatial Profiling

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response.

Jul

Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Jul

Featured Webinar

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector

“If we build it, they will come” is a familiar refrain that echoes in life science entrepreneurial circles. Too frequently startups believe that if a technology is built it will sell.

Aug

Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Menu

Pediatric Precision Oncology Study Matches 28 Percent of Patients to Targeted Therapies

To read the full story....

Breaking News

Noridian Providing Limited Coverage for MDx Tests as Predictive Classifiers for NSCLC

Syapse Partners With Ajou University Hospital to Expand Real-World Data Network in Asia

Illumina Acquires French Genomic Data-Compression Startup Enancio

Phenylketonuria Genotypes Vary With Geography, Disease Severity in International Study

Canadian Consortium Launches C$2.6M Liquid Biopsy Initiative to Improve Targeted Cancer Treatment

Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO

Recent Headlines from
Precision Oncology News

Notable's Drug Sensitivity Assay IDs Rx for Blood Cancer Patients When NGS Can't, Small Study Shows

Discovery of Inherited Mutation Sheds Light on Increased Cancer Risk in Brazilians

Case Study Supports Potential First-Line Use of Vitrakvi in NTRK Fusion-Positive Glioblastoma

Lantern Pharma Making Headway in Using AI to Revive Old Drugs, Develop New Compounds

Precision Oncology Trials Still Enroll Mostly White Patients Despite Initiatives, Calls to Diversify

Featured White Papers

Exploring Tumor Tissue Architecture and Immune Response with Digital Spatial Profiling

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

What's Popular?

Glioblastoma Brain Tumor Treatment Strategies Stem From Pharmacogenomic Analysis

Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

Canadian Consortium Launches C$2.6M Liquid Biopsy Initiative to Improve Targeted Cancer Treatment

Piper Sandler Initiates Coverage of Progenity With Overweight Rating

Merus, Caris Life Sciences Partner to ID NRG1 Fusion-Positive Cancer Patients for Clinical Trial

Sponsorships